JB

Jorge Becerril

Partner at Novo Holdings Venture Investments / Public Equity

San Francisco, California

Investor
VC

Invests in

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Biopharmaceuticals
Lifesciences
Management Consulting
Hardware Diagnostics
Medical Devices
Data Analysis
Start-ups
Life Science Industry
Pharmaceutical Industry
Biotechnology
Healthcare
Financial Modeling
Revenue Forecasting
Valuation
Due Diligence
Strategic Consulting
Corporate Development
Commercialization
Drug Discovery
Market Analysis

Education

Work Experience

Novo Holdings

2021

  • Partner - Venture Investments / Public Equity Team

    2024

  • Principal - Venture Investments

    2021 - 2024

Global Blood Therapeutics

2017 - 2021

  • Executive Director, Corporate Development

    2021 - 2021

  • Senior Director, Corporate Development

    2017 - 2021

    Source, evaluate, and negotiate in-licensing and M&A transactions in the orphan disease space Lead partner selection and negotiations of agreements for ex-US Oxbryta commercialization

Portola Pharmaceuticals

2014 - 2017

  • Director, Business Development

    2014 - 2017

    Source, evaluate, and negotiate in-licensing and M&A transactions in the areas hematology, immunology, oncology, and cardiovascular disease

L.E.K. Consulting

2010 - 2014

  • Senior Consultant, Life Sciences Practice

    2010 - 2014

    Led strategy and investment due diligence engagements for a variety of life sciences clients including startup and large biopharma as well as medtech, diagnostics, research tools and private equity firms

Yale University

2009 - 2010

  • Postdoctoral Associate

    2009 - 2010

Boston University

2007 - 2008

  • Postdoctoral Researcher

    2007 - 2008

    Developed chemical methodologies to create libraries of structurally complex molecules for biological screening